when switching from semaglutide to tirzepatide switching from semaglutide to tirzepatide

Semaglutide produced roughly 15% average body-weight loss in the STEP trials over 68 weeks (Wilding et al., N Engl J Med, 2021)

Want to speed things up

Its ability to reduce wrinkles, improve skin elasticity, and offer a safe, non-invasive alternative to Botox makes it a valuable ingredient in modern skincare formulations

Dunn AL, Reigle TG, Youngstedt SD, Armstrong RB, Dishman RK

Accessing Weight Loss Medicines Safely Through UK Healthcare NICE-approved options including semaglutide (Wegovy) and tirzepatide (Zepbound) are available through NHS specialist weight management services or CQC- and GPhC-regulated private providers following a clinical consultation